Iodixanol
- Generic Name
- Iodixanol
- Brand Names
- Visipaque, Visipaque 270, Visipaque 320
- Drug Type
- Small Molecule
- Chemical Formula
- C35H44I6N6O15
- CAS Number
- 92339-11-2
- Unique Ingredient Identifier
- HW8W27HTXX
- Background
Iodixanol is a nonionic hydrophilic compound commonly used as a contrast agent during coronary angiography, particularly in individuals with renal dysfunction, as it is believed to be less toxic to the kidneys than most other intravascular contrast agents.
- Indication
Iodixanol is a contrast agent during coronary angiography.
- Associated Conditions
- -
- Associated Therapies
- -
Nephrotoxicity of Iopamidol Versus Iodixanol in High-Risk Patients
- Conditions
- Interventions
- First Posted Date
- 2011-07-26
- Last Posted Date
- 2013-08-28
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 204
- Registration Number
- NCT01402219
- Locations
- 🇨🇳
Guangdong Cardiovascular Institute,Guangdong General Hospital, Guangzhou, Guangdong, China
Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed Tomographic Imaging of Abdomen/Pelvis
- First Posted Date
- 2011-06-20
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 304
- Registration Number
- NCT01376089
- Locations
- 🇺🇸
GE Healthcare, Princeton, New Jersey, United States
Prognostic Value of Baseline Computed Tomography (CT) Perfusion Parameters of Pancreatic Cancer for Patients Undergoing Stereotactic Body Radiotherapy or Surgical Resection
- Conditions
- First Posted Date
- 2011-03-30
- Last Posted Date
- 2016-07-01
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 6
- Registration Number
- NCT01326364
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
Pulmonary Interstitial Lymphography in Early Stage Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2010-08-25
- Last Posted Date
- 2018-04-17
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 12
- Registration Number
- NCT01188486
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
DynaCT in Preoperative Imaging Before Insertion of Stentgraft
- Conditions
- Interventions
- First Posted Date
- 2010-06-17
- Last Posted Date
- 2017-01-18
- Lead Sponsor
- Norwegian University of Science and Technology
- Target Recruit Count
- 20
- Registration Number
- NCT01146639
- Locations
- 🇳🇴
St Olavs Hospital, Operating Room of the Future., Trondheim, Norway
Isovue in Peripheral Digital Subtraction Angiography (DSA)
- Conditions
- Interventions
- First Posted Date
- 2010-02-25
- Last Posted Date
- 2013-05-30
- Lead Sponsor
- Bracco Diagnostics, Inc
- Target Recruit Count
- 174
- Registration Number
- NCT01075217
- Locations
- 🇺🇸
Bracco Diagnostics, Princeton, New Jersey, United States
Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI)
- Conditions
- Interventions
- First Posted Date
- 2009-01-23
- Last Posted Date
- 2010-11-16
- Lead Sponsor
- Ospedale San Donato
- Target Recruit Count
- 432
- Registration Number
- NCT00827788
- Locations
- 🇮🇹
Cardiovascular Department, Ospedale S.Donato, Arezzo, AR, Italy
Renal Safety of Iopamidol Versus Iodixanol During Coronary Angiography in Diabetic Patients
- Conditions
- Interventions
- First Posted Date
- 2008-10-31
- Last Posted Date
- 2012-01-26
- Lead Sponsor
- Bracco Diagnostics, Inc
- Target Recruit Count
- 23
- Registration Number
- NCT00782639
- Locations
- 🇺🇸
Bracco Diagnostics Inc., Princeton, New Jersey, United States
Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral DSA
- Conditions
- Interventions
- First Posted Date
- 2008-08-22
- Last Posted Date
- 2011-05-09
- Lead Sponsor
- Bracco Diagnostics, Inc
- Target Recruit Count
- 33
- Registration Number
- NCT00740207
Mechanisms for the Effect of Acetylcysteine on Renal Function After Exposure to Radiographic Contrast Material
- Conditions
- Interventions
- First Posted Date
- 2007-11-14
- Last Posted Date
- 2015-06-08
- Lead Sponsor
- University of Edinburgh
- Target Recruit Count
- 90
- Registration Number
- NCT00558142
- Locations
- 🇬🇧
Clinical Research Facility, Royal Infirmary Edinburgh, Edinburgh, Midlothian, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.